Genetic abnormalities involved in t(12;21) TEL-AML1 acute lymphoblastic leukemia: Analysis by means of array-based comparative genomic hybridization

Cancer Science

Volumn 98, Issue 5, 2007, Pages 698-706

  Tsuzuki, Shinobu ^a   Karnan, Sivasundaram ^a,b   Horibe, Keizo ^c   Matsumoto, Kimikazu ^d   Kato, Koji ^d   Inukai, Takeshi ^e   Goi, Kumiko ^e   Sugita, Kanji ^e   Nakazawa, Shinpei ^e   Kasugai, Yumiko ^a   Ueda, Ryuzo ^b   Seto, Masao ^a  

^a Aichi Cancer Center Research Institute   (United States)

^b NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

^c NATIONAL HOSPITAL ORGANIZATION NAGOYA MEDICAL CENTER   (Japan)

^d JAPANESE RED CROSS NAGOYA FIRST HOSPITAL   (Japan)

^e UNIVERSITY OF YAMANASHI   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ARF PROTEIN; ATM PROTEIN; CHROMOSOME PROTEIN; PROTEIN AIM1; PROTEIN BLIMP1; PROTEIN BTG1; PROTEIN LIMD1; PROTEIN NR3C2; PROTEIN P16INK4A; PROTEIN PDCD5; TRANSCRIPTION FACTOR ETV6; TRANSCRIPTION FACTOR PAX5; TRANSCRIPTION FACTOR RUNX1; UNCLASSIFIED DRUG;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ARTICLE; CELL PROLIFERATION; CHILD; CHROMOSOME 10; CHROMOSOME 11Q; CHROMOSOME 12P; CHROMOSOME 12Q; CHROMOSOME 19Q; CHROMOSOME 21Q; CHROMOSOME 3P; CHROMOSOME 4Q; CHROMOSOME 6Q; CHROMOSOME 9P; CHROMOSOME ABERRATION; CHROMOSOME TRANSLOCATION 12; CLINICAL ARTICLE; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; FEMALE; GENE LOCATION; GENETIC DISORDER; GENETIC IDENTIFICATION; GENOME; HUMAN; LEUKEMOGENESIS; MALE; MICROARRAY ANALYSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADOLESCENT; CELL LINE, TUMOR; CELL PROLIFERATION; CHILD; CHILD, PRESCHOOL; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 12; CHROMOSOMES, HUMAN, PAIR 21; CORE BINDING FACTOR ALPHA 2 SUBUNIT; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION REGULATION, NEOPLASTIC; GENOME, HUMAN; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LEUKEMIA, LYMPHOCYTIC, ACUTE, L1; MALE; NEOPLASM PROTEINS; NUCLEIC ACID HYBRIDIZATION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; ONCOGENE PROTEINS, FUSION; TRANSLOCATION, GENETIC;

EID: 34147153999     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2007.00443.x     Document Type: Article

References (63)

1. Greaves MF, Maia AT, Wiemels JL, Ford AM. Leukemia in twins: Lessons in natural history. Blood 2003; 102: 2321-33.
2. Zelent A, Greaves M, Enver T. Role of the TEL-AML1 fusion gene in the molecular pathogenesis of childhood acute lymphoblastic leukaemia. Oncogene 2004; 23: 4275-83.
3. Bernardin F, Yang Y, Cleaves R et al. TEL-AML1, expressed from t(12;21) in human acute lymphocytic leukemia, induces acute leukemia in mice. Cancer Res 2002; 62: 3904-8.
4. Tsuzuki S, Seto M, Greaves M, Enver T. Modeling first-hit functions of the t(12;21) TEL-AML1 translocation in mice. Proc Natl Acad Sci USA 2004; 101: 8443-8.
5. Morrow M, Horton S, Kioussis D, Brady HJ, Williams O. TEL-AML1 promotes development of specific hematopoietic lineages consistent with preleukemic activity. Blood 2004; 103: 3890-6.
6. Ma SK, Wan TS, Cheuk AT et al. Characterization of additional genetic events in childhood acute lymphoblastic leukemia with TEL/AML1 gene fusion: A molecular cytogenetics study. Leukemia 2001; 15: 1442-7.
7. Kanerva J, Niini T, Vettenranta K et al. Loss at 12p detected by comparative genomic hybridization (CGH): Association with TEL-AML1 fusion and favorable prognostic features in childhood acute lymphoblastic leukemia (ALL): A multi-institutional study. Med Pediatr Oncol 2001; 37: 419-25.
8. Cave H, Cacheux V, Raynaud S et al. ETV6 is the target of chromosome 12p deletions in t(12;21) childhood acute lymphocytic leukemia. Leukemia 1997; 11: 1459-64.
9. Montpetit A, Larose J, Boily G, Langlois S, Trudel N, Sinnett D. Mutational and expression analysis of the chromosome 12p candidate tumor suppressor genes in pre-B acute lymphoblastic leukemia. Leukemia 2004; 18: 1499-504.
10. Raimondi SC, Shurtleff SA, Downing JR et al. 12p abnormalities and the TEL gene (ETV6) in childhood acute lymphoblastic leukemia. Blood 1997; 90: 4559-66.
11. Raynaud S, Cave H, Baens M et al. The 12;21 translocation involving TEL and deletion of the other TEL allele: Two frequently associated alterations found in childhood acute lymphoblastic leukemia. Blood 1996; 87: 2891-9.
12. Patel N, Goff LK, Clark T et al. Expression profile of wild-type ETV6 in childhood acute leukaemia. Br J Haematol 2003; 122: 94-8.
13. Wlodarska I, Baens M, Peeters P et al. Biallelic alterations of both ETV6 and CDKN1B genes in a t(12;21) childhood acute lymphoblastic leukemia case. Cancer Res 1996; 56: 2655-61.
14. Attarbaschi A, Mann G, Konig M et al. Austrian Berlin-Frankfurt-Munster cooperative Study Group. Incidence and relevance of secondary chromosome abnormalities in childhood TEL/AML1+ acute lymphoblastic leukemia: An interphase FISH analysis. Leukemia 2004; 18: 1611-16.
15. Hu J, Khanna V, Jones M, Surti U. Chromosomal imbalances in uterine leiomyosarcomas: Potential markers for clinical diagnosis and prognosis. Genes Chromosomes Cancer 2001; 31: 117-24.
16. Franke S, Wlodarska I, Maes B et al. Lymphocyte predominance Hodgkin disease is characterized by recurrent genomic imbalances. Blood 2001; 97: 1845-53.
17. Tagawa H, Karnan S, Suzuki R et al. Genome-wide array-based CGH for mantle cell lymphoma: Identification of homozygous deletions of the proapoptotic gene BIM. Oncogene 2005; 24: 1348-58.
18. Kameoka Y, Tagawa H, Tsuzuki S et al. Contig array CGH at 3p14.2 points to the FRA3B/FHIT common fragile region as the target gene in diffuse large B-cell lymphoma. Oncogene 2004; 23: 9148-54.
19. Pinkel D, Segraves R, Sudar D et al. High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays. Nat Genet 1998; 20: 207-11.
20. Ota A, Tagawa H, Karnan S et al. Identification and characterization of a novel gene, C13orf25, as a target for 13q31-q32 amplification in malignant lymphoma. Cancer Res 2004; 64: 3087-95.
21. Tagawa H, Tsuzuki S, Suzuki R et al. Genome-wide array-based comparative genomic hybridization of diffuse large B-cell lymphoma: Comparison between CD5-positive and CD5-negative cases. Cancer Res 2004; 64: 5948-55.
22. Raynaud SD, Dastugue N, Zoccola D, Shurtleff SA, Mathew S, Raimondi SC. Cytogenetic abnormalities associated with the t(12;21): A collaborative study of 169 children with t(12;21)-positive acute lymphoblastic leukemia. Leukemia 1999; 13: 1325-30.
23. Martineau M, Jalali GR, Barber KE et al. ETV6/RUNX1 fusion at diagnosis and relapse: Some prognostic indications. Genes Chromosomes Cancer 2005; 43: 54-71.
24. Mosse YP, Greshock J, Margolin A et al. High-resolution detection and mapping of genomic DNA alterations in neuroblastoma. Genes Chromosomes Cancer 2005; 43: 390-403.
25. Senchenko VN, Liu J, Loginov W et al. Discovery of frequent homozygous deletions in chromosome 3p21.3 LUCA and AP20 regions in renal, lung and breast carcinomas. Oncogene 2004; 23: 5719-28.
26. Tischoff I, Markwarth A, Witzigmann H et al. Allele loss and epigenetic inactivation of 3p21.3 in malignant liver tumors. Int J Cancer 2005; 115: 684-9.
27. Sharp TV, Munoz F, Bourboulia D et al. LIM domains-containing protein 1 (LIMD1), a tumor suppressor encoded at chromosome 3p21.3, binds pRB and represses E2F-driven transcription. Proc Natl Acad Sci USA 2004; 101: 16 531-6.
28. Kiss H, Yang Y, Kiss C et al. The transcriptional map of the common eliminated region 1 (C3CER1) in 3p21.3. Eur J Hum Genet 2002; 10: 52-61.
29. Knosel T, Schluns K, Stein U et al. Genetic imbalances with impact on survival in colorectal cancer patients. Histopathology 2003; 43: 323-31.
30. Dave BJ, Nelson M, Pickering DL et al. Cytogenetic characterization of diffuse large cell lymphoma using multi-color fluorescence in situ hybridization. Cancer Genet Cytogenet 2002; 132: 125-32.
31. Jackson A, Carrara P, Duke V et al. Deletion of 6q16-q21 in human lymphoid malignancies: A mapping and deletion analysis. Cancer Res 2000; 60: 2775-9.
32. Takeuchi S, Koike M, Seriu T et al. Frequent loss of heterozygosity on the long arm of chromosome 6: Identification of two distinct regions of deletion in childhood acute lymphoblastic leukemia. Cancer Res 1998; 58: 2618-23.
33. Merup M, Moreno TC, Heyman M et al. 6q deletions in acute lymphoblastic leukemia and non-Hodgkin's lymphomas. Blood 1998; 91: 3397-400.
34. Gerard B, Cave H, Guidal C, Dastugue N, Vilmer E, Grandchamp B. Delineation of a 6 cM commonly deleted region in childhood acute lymphoblastic leukemia on the 6q chromosomal arm. Leukemia 1997; 11: 228-32.
35. Sherratt T, Morelli C, Boyle JM, Harrison CJ. Analysis of chromosome 6 deletions in lymphoid malignancies provides evidence for a region of minimal deletion within a 2-megabase segment of 6q21. Chromosome Res 1997; 5: 118-24.
36. Menasce LP, Orphanos V, Santibanez-Koref M, Boyle JM, Harrison CJ. Deletion of a common region on the long arm of chromosome 6 in acute lymphoblastic leukaemia. Genes Chromosomes Cancer 1994; 10: 26-9.
37. Zhang Y, Matthiesen P, Harder S et al. A 3-cM commonly deleted region in 6q21 in leukemias and lymphomas delineated by fluorescence in situ hybridization. Genes Chromosomes Cancer 2000; 27: 52-8.
38. Ray ME, Wistow G, Su YA, Meltzer PS, Trent JM. AIM1, a novel non-lens member of the betagamma-crystallin superfamily, is associated with the control of tumorigenicity in human malignant melanoma. Proc Natl Acad Sci USA 1997; 94: 3229-34.
39. Burgering BM, Kops GJ. Cell cycle and death control: Long live forkheads. Trends Biochem Sci 2002; 27: 352-60.
40. Schebesta M, Heavey B, Busslinger M. Transcriptional control of B-cell development. Curr Opin Immunol 2002; 14: 216-23.
41. Kim SK, Ro JY, Kemp BL et al. Identification of three distinct tumor suppressor loci on the short arm of chromosome 9 in small cell lung cancer. Cancer Res 1997; 57: 400-3.
42. Park SY, Kim YH, In KH, Chun YH, Park SH. Chromosomal aberrations in Korean nonsmall cell lung carcinomas: Degenerate oligonucleotide primed polymerase chain reaction comparative genomic hybridization studies. Cancer Genet Cytogenet 2004; 152: 153-7.
43. Busslinger M, Klix N, Pfeffer P, Graninger PG, Kozmik Z. Deregulation of PAX-5 by translocation of the Emu enhancer of the IgH locus adjacent to two alternative PAX-5 promoters in a diffuse large-cell lymphoma. Proc Natl Acad Sci USA 1996; 93: 6129-34.
44. Iida S, Rao PH, Nallasivam P et al. The t(9;14) (p13;q32) chromosomal translocation associated with lymphoplasmacytoid lymphoma involves the PAX-5 gene. Blood 1996; 88: 4110-17.
45. Sherr CJ. Principles of tumor suppression. Cell 2004; 116: 235-6.
46. Eclache V, Caulet-Maugendre S, Poirel HA et al. Cryptic deletion involving the ATM locus at 11q22.3 approximately q23.1 in B-cell chronic lymphocytic leukemia and related disorders. Cancer Genet Cytogenet 2004; 152: 72-6.
47. Cuneo A, Bigoni R, Rigolin GM et al. Late appearance of the 11q22.3-23.1 deletion involving the ATM locus in B-cell chronic lymphocytic leukemia and related disorders: Clinico-biological significance. Haematologica 2002; 87: 44-51.
48. Boultwood J. Ataxia telangiectasia gene mutations in leukaemia and lymphoma. J Clin Pathol 2001; 54: 512-16.
49. Gumy Pause F, Wacker P, Maillet P, Betts D, Sappino AP. ATM gene alterations in childhood acute lymphoblastic leukemias. Hum Mutat 2003; 21: 554.
50. Bullrich F, Rasio D, Kitada S et al. ATM mutations in B-cell chronic lymphocytic leukemia. Cancer Res 1999; 59: 24-7.
51. Rouault JP, Rimokh R, Tessa C et al. BTG1, a member of a new family of antiproliferative genes. EMBO J 1992; 11: 1663-70.
52. Kuo ML, Duncavage EJ, Mathew R et al. Arf induces p53-dependent and -independent antiproliferative genes. Cancer Res 2003; 63: 1046-53.
53. Matsuda S, Rouault J, Magaud J, Berthet C. In search of a function for the TIS21/PC3/BTG1/TOB family. FEBS Lett 2001; 497: 67-72.
54. Barbashina V, Salazar P, Holland EC, Rosenblum MK, Ladanyi M. Allelic losses at 1p36 and 19q13 in gliomas: Correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene. Clin Cancer Res 2005; 11: 1119-28.
55. Smith JS, Tachibana I, Lee HK et al. Mapping of the chromosome 19 q-arm glioma tumor suppressor gene using fluorescence in situ hybridization and novel microsatellite markers. Genes Chromosomes Cancer 2000; 29: 16-25.
56. Liu H, Wang Y, Zhang Y et al. TFAR19, a novel apoptosis-related gene cloned from human leukemia cell line TF-1, could enhance apoptosis of some tumor cells induced by growth factor withdrawal. Biochem Biophys Res Commun 1999; 254: 203-10.
57. Kibel AS, Freije D, Isaacs WB, Bova GS. Deletion mapping at 12p12-13 in metastatic prostate cancer. Genes Chromosomes Cancer 1999; 25: 270-6.
58. Latil A, Guerard M, Berthon P, Cussenot O. 12p12-13 deletion in prostate tumors and quantitative expression of CDKN1B and ETV6 candidate genes. Genes Chromosomes Cancer 2001; 31: 199-200.
59. Knuutila S, Aalto Y, Autio K et al. DNA copy number losses in human neoplasms. Am J Pathol 1999; 155: 683-94.
60. Speck NA, Gilliland DG. Core-binding factors in haematopoiesis and leukaemia. Nat Rev Cancer 2002; 2: 502-13.
61. Armstrong SA, Mabon ME, Silverman LB et al. FLT3 mutations in childhood acute lymphoblastic leukemia. Blood 2004; 103: 3544-6.
62. Fenrick R, Wang L, Nip J et al. TEL, a putative tumor suppressor, modulates cell growth and cell morphology of ras-transformed cells while repressing the transcription of stromelysin-1. Mol Cell Biol 2000; 20: 5828-39.
63. 1 arrest and suppresses Ras-induced transformation. Oncogene 2000; 19: 5244-50.